Extract

Study of SB-681323 (a novel p38 MAPkinase inhibitor) in subjects with documented coronary heart disease (CHD) undergoing elective percutaneous coronary intervention (PCI).

Inclusion criteria

• Coronary Heart Disease

Links

• nct
• ictrp